Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

Erratum to: Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma.

Simeone E, Gentilcore G, Giannarelli D, Grimaldi AM, Caracò C, Curvietto M, Esposito A, Paone M, Palla M, Cavalcanti E, Sandomenico F, Petrillo A, Botti G, Fulciniti F, Palmieri G, Queirolo P, Marchetti P, Ferraresi V, Rinaldi G, Pistillo MP, Ciliberto G, Mozzillo N, Ascierto PA.

Cancer Immunol Immunother. 2014 Nov;63(11):1233. doi: 10.1007/s00262-014-1611-2. No abstract available.

PMID:
25253532
[PubMed - in process]
2.

Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy.

Grimaldi AM, Simeone E, Giannarelli D, Muto P, Falivene S, Borzillo V, Giugliano FM, Sandomenico F, Petrillo A, Curvietto M, Esposito A, Paone M, Palla M, Palmieri G, Caracò C, Ciliberto G, Mozzillo N, Ascierto PA.

Oncoimmunology. 2014 May 14;3:e28780. eCollection 2014.

PMID:
25083318
[PubMed]
Free PMC Article
3.

Number of excised lymph nodes as a quality assurance measure for lymphadenectomy in melanoma.

Rossi CR, Mozzillo N, Maurichi A, Pasquali S, Macripò G, Borgognoni L, Solari N, Piazzalunga D, Mascheroni L, Giudice G, Mocellin S, Patuzzo R, Caracò C, Ribero S, Marone U, Santinami M.

JAMA Surg. 2014 Jul;149(7):700-6. doi: 10.1001/jamasurg.2013.5676.

PMID:
24804856
[PubMed - indexed for MEDLINE]
4.

Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma.

Simeone E, Gentilcore G, Giannarelli D, Grimaldi AM, Caracò C, Curvietto M, Esposito A, Paone M, Palla M, Cavalcanti E, Sandomenico F, Petrillo A, Botti G, Fulciniti F, Palmieri G, Queirolo P, Marchetti P, Ferraresi V, Rinaldi G, Pistillo MP, Ciliberto G, Mozzillo N, Ascierto PA.

Cancer Immunol Immunother. 2014 Jul;63(7):675-83. doi: 10.1007/s00262-014-1545-8. Epub 2014 Apr 3.

PMID:
24695951
[PubMed - indexed for MEDLINE]
5.

Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study.

Pasquali S, Mocellin S, Mozzillo N, Maurichi A, Quaglino P, Borgognoni L, Solari N, Piazzalunga D, Mascheroni L, Giudice G, Patuzzo R, Caracò C, Ribero S, Marone U, Santinami M, Rossi CR.

J Clin Oncol. 2014 Mar 20;32(9):935-41. doi: 10.1200/JCO.2013.50.7681. Epub 2014 Feb 10.

PMID:
24516022
[PubMed - indexed for MEDLINE]
6.

Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma.

Aloj L, D'Ambrosio L, Aurilio M, Morisco A, Frigeri F, Caraco' C, Di Gennaro F, Capobianco G, Giovannoni L, Menssen HD, Neri D, Pinto A, Lastoria S.

Eur J Nucl Med Mol Imaging. 2014 May;41(5):867-77. doi: 10.1007/s00259-013-2658-6. Epub 2014 Jan 17.

PMID:
24435772
[PubMed - in process]
7.

The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis.

Rossi CR, Mozzillo N, Maurichi A, Pasquali S, Quaglino P, Borgognoni L, Solari N, Piazzalunga D, Mascheroni L, Giudice G, Mocellin S, Patuzzo R, Caracò C, Ribero S, Marone U, Santinami M.

Ann Oncol. 2014 Jan;25(1):240-6. doi: 10.1093/annonc/mdt510.

PMID:
24356635
[PubMed - indexed for MEDLINE]
8.

Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis.

Caracò C, Mozzillo N, Marone U, Simeone E, Benedetto L, Di Monta G, Di Cecilia ML, Botti G, Ascierto PA.

BMC Cancer. 2013 Dec 1;13:564. doi: 10.1186/1471-2407-13-564.

PMID:
24289268
[PubMed - indexed for MEDLINE]
Free Article
9.

Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.

Lastoria S, Piccirillo MC, Caracò C, Nasti G, Aloj L, Arrichiello C, de Lutio di Castelguidone E, Tatangelo F, Ottaiano A, Iaffaioli RV, Izzo F, Romano G, Giordano P, Signoriello S, Gallo C, Perrone F.

J Nucl Med. 2013 Dec;54(12):2062-9. doi: 10.2967/jnumed.113.119909. Epub 2013 Oct 17.

PMID:
24136935
[PubMed - indexed for MEDLINE]
10.

Surgical management of sentinel lymph node biopsy outside major nodal basin in patients with cutaneous melanoma.

Caracò C, Marone U, Di Monta G, Aloj L, Caracò C, Anniciello A, Lastoria S, Botti G, Mozzillo N.

Ann Surg Oncol. 2014 Jan;21(1):300-5. doi: 10.1245/s10434-013-3285-y. Epub 2013 Oct 1.

PMID:
24081802
[PubMed - indexed for MEDLINE]
11.

Electrochemotherapy as "new standard of care" treatment for cutaneous Kaposi's sarcoma.

Di Monta G, Caracò C, Benedetto L, La Padula S, Marone U, Tornesello ML, Buonaguro FM, Simeone E, Ascierto PA, Mozzillo N.

Eur J Surg Oncol. 2014 Jan;40(1):61-6. doi: 10.1016/j.ejso.2013.09.002. Epub 2013 Sep 12.

PMID:
24075826
[PubMed - indexed for MEDLINE]
12.

Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma.

Colombino M, Lissia A, Capone M, De Giorgi V, Massi D, Stanganelli I, Fonsatti E, Maio M, Botti G, Caracò C, Mozzillo N, Ascierto PA, Cossu A, Palmieri G.

J Transl Med. 2013 Aug 29;11:202. doi: 10.1186/1479-5876-11-202.

PMID:
23987572
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Sentinel node biopsy in thin and thick melanoma.

Mozzillo N, Pennacchioli E, Gandini S, Caracò C, Crispo A, Botti G, Lastoria S, Barberis M, Verrecchia F, Testori A.

Ann Surg Oncol. 2013 Aug;20(8):2780-6. doi: 10.1245/s10434-012-2826-0. Epub 2013 May 30.

PMID:
23720068
[PubMed - indexed for MEDLINE]
14.

Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial.

Nasti G, Piccirillo MC, Izzo F, Ottaiano A, Albino V, Delrio P, Romano C, Giordano P, Lastoria S, Caracò C, de Lutio di Castelguidone E, Palaia R, Daniele G, Aloj L, Romano G, Iaffaioli RV.

Br J Cancer. 2013 Apr 30;108(8):1566-70. doi: 10.1038/bjc.2013.140. Epub 2013 Apr 4.

PMID:
23558891
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma.

Daponte A, Signoriello S, Maiorino L, Massidda B, Simeone E, Grimaldi AM, Caracò C, Palmieri G, Cossu A, Botti G, Petrillo A, Lastoria S, Cavalcanti E, Aprea P, Mozzillo N, Gallo C, Comella G, Ascierto PA; Southern Italy Cooperative Oncology Group (SICOG).

J Transl Med. 2013 Feb 13;11:38. doi: 10.1186/1479-5876-11-38.

PMID:
23402397
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Superficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors.

Mozzillo N, Caracò C, Marone U, Di Monta G, Crispo A, Botti G, Montella M, Ascierto PA.

World J Surg Oncol. 2013 Feb 4;11:36. doi: 10.1186/1477-7819-11-36.

PMID:
23379355
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Collagen sealant patch to reduce lymphatic drainage after lymph node dissection.

Di Monta G, Caracò C, Crispo A, Marone U, Mozzillo N.

World J Surg Oncol. 2012 Dec 19;10:275. doi: 10.1186/1477-7819-10-275.

PMID:
23253298
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Positron emission tomography and circulating tumor cells to monitor a dramatic response to gefitinib.

Morabito A, Sandomenico C, Costanzo R, Montanino A, Caraco C, De Lutio E, Bevilacqua S, Pasquale R, Caronna A, Botti G, Normanno N, Rocco G.

J Thorac Oncol. 2012 Nov;7(11):e27-8. doi: 10.1097/JTO.0b013e3182653da2. No abstract available.

PMID:
23070247
[PubMed - indexed for MEDLINE]
19.

Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer: correlation with long-term outcome.

Avallone A, Aloj L, Caracò C, Delrio P, Pecori B, Tatangelo F, Scott N, Casaretti R, Di Gennaro F, Montano M, Silvestro L, Budillon A, Lastoria S.

Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1848-57. doi: 10.1007/s00259-012-2229-2. Epub 2012 Oct 5.

PMID:
23053320
[PubMed - indexed for MEDLINE]
20.

Update on PEG-interferon α-2b as adjuvant therapy in melanoma.

Di Trolio R, Simeone E, Di Lorenzo G, Grimaldi AM, Romano A, Ayala F, Caracò C, Mozzillo N, Ascierto PA.

Anticancer Res. 2012 Sep;32(9):3901-9. Review.

PMID:
22993335
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk